In the News

Harwich Port woman blindsided by chemotherapy

Admin • CCON • 11/29/2015

Breast cancer was a devastating diagnosis for Kathleen Mingle, a teacher who played tennis, ran and generally led an active and fit life. But the shock was compounded when she... Read more »

Read More...

CCC 2015: Improving Cardiac Care for Cancer Patients

Admin • CCON • 11/19/2015

CCS Position Statement Dr. Dent, co-founder of the Ottawa Cardiology-Oncology Clinic at The Ottawa Hospital, led the session presenting the Canada Cardiovascular Society’s (CCS) first position statement on cardiovascular complications... Read more »

Read More...

NIH Funding Opportunity: Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21)

Admin • CCON • 11/17/2015

This Funding Opportunity Announcement (FOA) encourages collaborative applications that will contribute to the identification and characterization of patients at risk of developing cancer treatment-related cardiotoxicity. The primary intent is to... Read more »

Read More...

AHA: Candesartan May Preserve Cardiac Function in Breast Ca Patients

Admin • CCON • 11/11/2015

ORLANDO — An angiotensin II receptor blocker may help to preserve cardiac function in patients receiving treatment for breast cancer, according to results of a small trial reported here. Read... Read more »

Read More...

Heart drugs during breast cancer treatment can help women avoid cardiac issues

Admin • CCON • 11/11/2015

ORLANDO, Fla. — Many cancer treatments have a dark side — they can damage the heart. New research suggests this risk might be lowered in women with breast tumors if... Read more »

Read More...

Lee Memorial collaborative focuses on cancer, heart disease

Admin • CCON • 11/9/2015

Most of us know heart disease is the No. 1 killer of Americans, followed closely by cancer. It is a lesser known fact that cancer therapy can cause adverse effects on... Read more »

Read More...

Cardiotoxicity Low for Patients Receiving Paclitaxel, Trastuzumab for ERBB2+ Breast Cancer

Admin • CCON • 11/6/2015

Cardiac toxic effects from paclitaxel with trastuzumab, presenting as grade 3 or 4 left ventricular systolic dysfunction (LVSD) or asymptomatic left ventricular ejection fraction decline (LVEF), were low in patients... Read more »

Read More...

The Connection Between Cancer Treatment and Cardiac Problems

Admin • CCON • 10/20/2015

When she was just a year old, Brenda Yano was diagnosed with acute leukemia. She was one of the lucky ones, cured by aggressive chemotherapy. Years later, Yano was told... Read more »

Read More...

Apply Today! Fellowship in “Cardiotoxcity Prevention” – Peter Munk Cardiac Center, Toronto General Hospital, UHN

Admin • CCON • 4/20/2015

The Ted Rogers Program in Cardiotoxicity Prevention at the Peter Munk Center will be offering a formal clinical / research fellowship in advanced heart failure and cardiotoxicity prevention starting July... Read more »

Read More...

Apply Today! Cardio-Oncology Fellowship Program

Admin • CCON • 2/2/2015

Two Cardio-Oncology Fellowship positions are available for the 2015-2016 academic year at both the Abramson Cancer Center at the University of Pennsylvania in Philadelphia, PA, and at the University of... Read more »

Read More...